Sanofi India peers

Companies like Sanofi Indialatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SANOFI₹2,992.00

Sanofi India Limited

· Pharma & Health
₹ CrorePeersSENORESINNOVACAPPGHLMOREPENLABIOLCPSANOFICONRFDCORCHPHARMAMcap ₹6,882 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SANOFI
FY26
SENORES
FY26
INNOVACAP
FY26
PGHL
FY27
Peer
Average
Valuation — at last close
P/E◆ 21.09×300.98×70.73×93.21×154.98× -86%
P/B9.19×8.13×◆ 6.77×—7.45× +23%
EV/EBITDA13.45×◆ -322.48×41.52×—-140.48× +110%
Market Cap₹6,882 Cr₹6,098 Cr₹6,007 Cr₹8,962 Cr₹7,023 Cr -2%
Growth
Revenue CAGR 3Y◆ -12.79%——-33.37%-33.37% +62%
Revenue CAGR 5Y◆ -8.74%——-18.46%-18.46% +53%
Net Income CAGR 3Y◆ -19.26%——-25.17%-25.17% +23%
Revenue YoY (latest Q)3.43%0.91%◆ 39.55%7.37%15.94% -78%
Net Income YoY (latest Q)53.55%20.06%◆ 57.97%45.29%41.11% +30%
Profitability
EBITDA Margin26.74%-17.61%11.65%◆ 27.38%7.14% +275%
Net Income Margin17.78%19.09%6.54%◆ 26.44%17.36% +2%
Return on Common Equity◆ 40.59%2.78%9.99%—6.38% +536%
Return on Capital Employed◆ 54.83%-3.96%10.33%—3.19% +1622%
Return on Assets◆ 22.79%2.35%5.83%—4.09% +457%
Credit & Quality
Total Debt/Equity◆ 0.00×0.10×0.36×—0.23× -100%
Interest Coverage267.06×-4.57×7.39×◆ 668.43×223.75× +19%
Scale — latest FY
Revenue / Total Income₹1,837 Cr₹106 Cr₹1,299 Cr₹364 Cr₹590 Cr +212%
Net Income₹327 Cr₹20.3 Cr₹84.9 Cr₹96.2 Cr₹67.1 Cr +387%
Total Assets₹1,255 Cr₹888 Cr₹1,547 Cr—₹1,217 Cr +3%
EPS₹141.85₹4.4₹14.84₹57.92₹25.72 +452%
Book Value per Share₹325.74₹162.84₹155.16—₹159 +105%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.